{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:23:15Z","timestamp":1781220195571,"version":"3.54.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Irreversible hearing loss is a well-known adverse effect of aminoglycosides, however, inability to accurately predict ototoxicity is a major limitation in clinical care. We addressed this limitation by developing a prediction model for aminoglycoside ototoxicity applicable to the general population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We employed a prospective non-drug-resistant tuberculosis (TB), non-HIV\/AIDS cohort of 153 adults on Streptomycin based anti-TB therapy. High frequency pure-tone audiometry was done at regular intervals throughout the study. Clinical and audiological predictors of ototoxicity were collated and ototoxic threshold shift from the baseline audiogram computed. The prediction model was developed with logistic regression method by examining multiple predictors of ototoxicity. Series of models were fitted sequentially; the best model was identified using Akaike Information Criterion and likelihood ratio test. Key variables in the final model were used to develop a logit model for ototoxicity prediction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Ototoxicity occurred in 35% of participants. Age, gender, weight, cumulative Streptomycin dosage, social class, baseline pure tone average (PTA) and prior hearing symptoms were explored as predictors. Multiple logistic regression showed that models with age, cumulative dosage and baseline PTA were best for predicting ototoxicity. Regression parameters for ototoxicity prediction showed that yearly age increment raised ototoxicity risk by 5% (AOR\u2009=\u20091.05; CI, 1.01\u20131.09), and a gram increase in cumulative dosage increased ototoxicity risk by 7% (AOR\u2009=\u20091.05; CI, 1.05\u20131.12) while a unit change in baseline log (PTA) was associated 254% higher risk of ototoxicity (AOR\u2009=\u20093.54, CI: 1.25, 10.01). Training and validation models had area under the receiver operating characteristic curve as 0.84 (CI, 0.76\u20130.92) and 0.79 (CI, 0.62\u20130.96) respectively, showing the model has discriminatory ability.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This model can predict aminoglycoside ototoxicity in the general population.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1461823","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T05:10:28Z","timestamp":1730437828000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive model for aminoglycoside induced ototoxicity"],"prefix":"10.3389","volume":"15","author":[{"given":"Adebolajo A.","family":"Adeyemo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Adeolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua O.","family":"Akinyemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayemi O.","family":"Omotade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odunayo M.","family":"Oluwatosin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"ref1","first-page":"622","article-title":"Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis","volume":"6","author":"De Jager","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6815-7-5","article-title":"Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up","volume":"7","author":"Duggal","year":"2007","journal-title":"BMC Ear Nose Throat Disord"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.mito.2004.07.040","article-title":"Mitochondrial dysfunction in hearing loss","volume":"4","author":"Fischel-Ghodsian","year":"2004","journal-title":"Mitochondrion"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3109\/00016486409137120","article-title":"Site of action of streptomycin upon inner ear sensory cells","volume":"57","author":"Duvall","year":"1964","journal-title":"Acta Otolaryngol"},{"key":"ref5","volume-title":"Pharmacology","author":"Finkel","year":"2009"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1172\/JCI112463","article-title":"Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs","volume":"77","author":"Huy","year":"1986","journal-title":"J Clin Invest"},{"key":"ref7","first-page":"93","volume-title":"Mechanisms for aminoglycoside ototoxicity: Basic science research. Ototoxicity","author":"Schacht","year":"2004"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3109\/00206099309072930","article-title":"Gentamicin uptake by cochlear hair cells precedes hearing impairment during chronic treatment","volume":"32","author":"Hiel","year":"1993","journal-title":"Audiology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0006-8993(95)01198-6","article-title":"Endocytosis of aminoglycoside antibiotics in sensory hair cells","volume":"704","author":"Hashino","year":"1995","journal-title":"Brain Res"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/jmg.20.5.357","article-title":"Familial aggregation of streptomycin ototoxicity: autosomal dominant inheritance?","volume":"20","author":"Viljoen","year":"1983","journal-title":"J Med Genet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.heares.2011.05.008","article-title":"New developments in aminoglycoside therapy and ototoxicity","volume":"281","author":"Xie","year":"2011","journal-title":"Pathol Inner Ear"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-5955(01)00224-6","article-title":"Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals","volume":"155","author":"Sha","year":"2001","journal-title":"Hear Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nrmicro2797","article-title":"Global tuberculosis control: lessons learnt and future prospects","volume":"10","author":"Lienhardt","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e1000427","DOI":"10.1371\/journal.pmed.1000427","article-title":"Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study","volume":"8","author":"Jones-L\u00f3pez","year":"2011","journal-title":"PLoS Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.11604\/pamj.2012.12.103.1716","article-title":"Antibiotic prescribing practice in management of cough and\/or diarrhoea in Moshi municipality, northern tanzania: cross-sectional descriptive study","author":"Gwimile","year":"2012","journal-title":"Pan Afr Med J"},{"key":"ref17","article-title":"Factsheets on deafness. World health","year":"2023","journal-title":"Organization"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s40064-016-2429-5","article-title":"Study of streptomycin-induced ototoxicity: protocol for a longitudinal study","volume":"5","author":"Adeyemo","year":"2016","journal-title":"Springerplus"},{"key":"ref19","first-page":"391","article-title":"Ototoxic effects of tuberculosis treatments: how aware are patients","volume":"3","author":"Katijah","year":"2009","journal-title":"Afr J Pharm Pharmacol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jamaoto.2013.1713","article-title":"Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy. JAMA","volume":"139","author":"Johnson","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref21","year":"1994"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2350-10-2","article-title":"A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness","volume":"10","author":"Bardien","year":"2009","journal-title":"BMC Med Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11892-011-0235-6","article-title":"A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future research","volume":"11","author":"Willems","year":"2011","journal-title":"Curr Diab Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1186\/ar3157","article-title":"Prediction model for knee osteoarthritis based on genetic and clinical information","volume":"12","author":"Takahashi","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1136\/ard.2009.123828","article-title":"Genetic variants in the prediction of rheumatoid arthritis","volume":"69","author":"van der Helm-van Mil","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-13-340","article-title":"Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study","volume":"13","author":"Sanders","year":"2013","journal-title":"BMC Infect Dis"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/cid\/ciz289","article-title":"Aminoglycoside-induced hearing loss among patients being treated for drug-resistant tuberculosis in South Africa: a prediction model","volume":"70","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1461823\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T05:10:33Z","timestamp":1730437833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1461823\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":27,"alternative-id":["10.3389\/fneur.2024.1461823"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1461823","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"article-number":"1461823"}}